Answers are grounded in this paper and cite their sources.
7505Background: Lisocabtagene maraleucel (liso-cel; JCAR017) is a CD19-directed 4-1BB CAR T cell product administered in defined composition at a precise dose of CD8 and CD4 CAR T cells. A multicen...
No takes yet. Share an insight, caveat, or question.
Abramson et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: